flow trial semaglutide kidney outcomes nejm 2024 hazard ratio significant 24% reduction in disease progression and death related to kidney and cardiovascular causes in those treated with compared to a placebo Kidney and Survival Outcomes with

Weight Loss While GLP-1 medications are an effective weight loss aid, results can vary based on the type of GLP-1 RA used and their dosage and duration

It identified that these drugs could also help control blood sugar and reduce inflammation in the brain while promoting nerve growth.

BMC Medicine, 18 (1), 248

Dispose of needles and empty vials in an FDA-cleared sharps container or follow local regulations

Safety and Side Effects GLP-1 receptor agonists are generally well-tolerated but can cause side effects

Additionally, this medication works on the GLP-1 receptors in the pancreas, brain, and gastrointestinal tract, triggering several weight loss mechanisms such as appetite suppression, delayed gastric emptying, increased satiety, reduced fat absorption, and increased metabolism